Summary
An inhibitor of glucose utilization in rat diaphragm was isolated from the serum of patients suffering from liver cirrhosis. This inhibitor is suggested to contribute to abnormal carbohydrate metabolism in liver diseases. It is a low molecular weight substance, probably of pepticle nature. It is identical with the inhibitor of glucose utilization isolated from the serum and urine of patients with renal failure and from the urine of healthy subjects.
Similar content being viewed by others
References
Creutzfeldt W., Frerichs H., Sickinger K.: Liver Diseases and Diabetes Mellitus — In:Popper H., Schaffner F. (Eds): Progress in Liver Disease. Grune and Stratton, New York, 1969; vol. 3, p. 371.
Dzúrik R., Hupková V., Černáček P., Valovičová E., Niederland T. R.: The Isolation of an Inhibitor of Glucose Utilization from the Serum of Uraemic Subjects — Clin. chim. Acta46, 77, 1973.
Dzúriková V., Niederland T. R., Brixová E., Dzúrik R., Hupková V., Holomáň J.: Abnormal Carbohydrate Metabolism in Patients with Liver Cirrhosis; in Vitro Study — Diabetologia8, 202, 1972.
Felber J.-P., Magnenat P., Vannotti A.: Tolérance au glucose diminuée et réponse insulinique élevée dans la cirrhose — Schweiz. med. Wschr.97, 1537, 1967.
Megyesi C., Samols E., Marks V.: Glucose Tolerance and Diabetes in Chronic Liver Disease — Lancet2, 1051, 1967.
Spustová-Hupková V., Černáček P., Dzúrik R.: The Isolation of the Inhibitor of Glucose Utilization from Urine of Uraemic and Healthy Subjects — Physiol. bohemoslov. (In press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dzúriková, V., Černáěk, P., Niederland, T.R. et al. Isolation of an inhibitor responsible for abnormal glucose utilization in liver disease. Acta diabet. lat 11, 277–282 (1974). https://doi.org/10.1007/BF02581232
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02581232